Timing and Predictors of Tuberculosis Incidence among Contacts

Timing and Predictors of Tuberculosis Incidence among Contacts

Publication date: Nov 03, 2024

Contact investigations are crucial for tuberculosis (TB) control, yet the temporal dynamics of disease progression among exposed contacts remain poorly understood. Here, we analyzed a retrospective cohort of 44,106 contacts of 6,243 TB cases identified through the Florida Department of Health surveillance system (2009-2023). During the 15-year follow-up period, 454 individuals within this cohort developed active TB disease. Using survival analysis and mixed-effect Cox proportional hazards models, we determined that the median time to TB disease onset was 11 months following the initial contact investigation. The risk of progression to TB disease varied markedly by age and immune status. Children aged 0-5 years showed nearly seven times higher risk of TB disease progression compared to adults 65 years and older (aHR = 6.66, 95% CI: 1.33-33.27). HIV-positive contacts demonstrated a five-fold increased risk (aHR = 4.75, 95% CI: 2.43-9.30) relative to HIV-negative individuals. These findings indicate that the risk of TB transmission and disease progression persists beyond initial contact investigation activities and varies significantly across demographic and clinical subgroups, suggesting the need for extended contact monitoring and age-specific preventive strategies, particularly for young children and immunocompromised individuals.

PDF

Concepts Keywords
Florida Certified
Formidable Contact
Tuberculosis Contacts
Ucla Copyright
Doi
Hiv
Https
Incident
License
Medrxiv
Peer
Preprint
Risk
Tuberculosis
Version

Semantics

Type Source Name
disease MESH Tuberculosis
pathway KEGG Tuberculosis
disease MESH disease progression
disease MESH Infectious Diseases
disease MESH infection
disease MESH latent infection
disease IDO process
disease IDO susceptibility
disease MESH HIV infection
pathway REACTOME HIV Infection
disease IDO history
disease MESH low socioeconomic status
disease IDO host
disease IDO intervention
disease MESH co infection
disease IDO drug susceptibility
drug DRUGBANK Ethanol
disease MESH substance use
pathway REACTOME Immune System
disease MESH privacy
disease MESH Latent Tuberculosis Infection
disease MESH pulmonary tuberculosis
disease MESH AIDS
disease IDO cell

Download Document

Leave a Comment

Your email address will not be published. Required fields are marked *